Top

Published in:

01-02-2019 | Brief Communication

The performance of patients with Parkinson’s disease on the Face-Name Associative Memory Examination

Authors: Constantinos Kormas, Ioannis Zalonis, Ioannis Evdokimidis, Constantin Potagas

Published in: Neurological Sciences | Issue 2/2019

Abstract

In this study, we examined the performance of patients with Parkinson’s disease (PD) with different cognitive profiles on the Face-Name Associative Memory Examination (FNAME). We evaluated 71 patients with a comprehensive neuropsychological battery. The results revealed that the group with executive and additional visuospatial deficits demonstrated significantly lower scores on FNAME. This finding indicates the possible clinical utility of FNAME for screening patients with PD with distinct cognitive profiles. Further longitudinal studies are needed to consider the prognostic adequacy of FNAME in detecting high-risk Parkinson’s disease dementia (PDD).

Pagonabarraga J, Kulisevsky J (2012) Cognitive impairment and dementia in Parkinson's disease. Neurobiol Dis 46:590–596CrossRef

Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson’s disease. Brain Pathol 20:633–639CrossRef

Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958–2969CrossRef

Kehagia AA, Barker RA, Robbins TW (2013) Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis. Neurodegener Dis 11:79–92CrossRef

Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, van Deerlin V, Lee VMY, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72:587–598CrossRef

Rentz DM, Amariglio RE, Becker JA, Frey M, Olson LE, Frishe K, Carmasin J, Maye JE, Johnson KA, Sperling RA (2011) Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychol 49(9):2776–2783CrossRef

Sanabria A et al (2018) The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline. Sci Rep 8(1):3828CrossRef

Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRef

Konstantopoulos K, Vogazianos P, Doskas T (2016) Normative data of the Montreal Cognitive Assessment in the Greek population and parkinsonian dementia. Arch Clin Neuropsychol 31(3):246–253CrossRef

10.

Partington JE, Leiter RG (1949) Partington’s pathway test. Psychol Service Center Bull 1:9–20

11.

Zalonis I, Kararizou E, Triantafyllou NI, Kapaki E, Papageorgiou S, Sgouropoulos PEEA, Vassilopoulos D (2008) A normative study of the trail making test A and B in Greek adults. Clin Neuropsychol 22:842–850CrossRef

12.

Zalonis et al (2009) The stroop effect in Greek healthy population: normative data for the stroop neuropsychological screening test. Arch Clin Neuropsychol 24:81–88CrossRef

13.

Rey A (1941) L’examen psychologique dans les cas d’encephalopathie traumatique (Les problems.). Archives de Psychologie 28:215–285

14.

Aretouli E, Kosmidis MH (2007) Rey–Osterrieth Complex Figure Test: Greek norms and cultural and demographic influences. Paper accepted to the 9th European Conference on Psychological Assessment & 2nd International Conference of the Psychological Society of Northern Greece

15.

Kormas C, Megalokonomou A, Zalonis I, Evdokimidis I, Kapaki E, Potagas C (2018) Development of the Greek version of the Face Name Associative Memory Exam (GR-FNAME12) in cognitively normal elderly individuals. Clin Neuropsychol 2:1–12. https://doi.org/10.1080/13854046.2018.1495270 CrossRef

16.

Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRef

17.

Biundo R, Weis L, Antonini A (2016) Cognitive decline in Parkinson’s disease: the complex picture. NPJ Parkinsons Dis 2:16018CrossRef

Title: The performance of patients with Parkinson’s disease on the Face-Name Associative Memory Examination
Authors: Constantinos Kormas
Ioannis Zalonis
Ioannis Evdokimidis
Constantin Potagas
Publication date: 01-02-2019
Publisher: Springer International Publishing
Published in: Neurological Sciences / Issue 2/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-018-3560-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The performance of patients with Parkinson’s disease on the Face-Name Associative Memory Examination

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2019

Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome

Dramatic improvement by levodopa treatment in a patient with vascular parkinsonism

Clinical variability of children with anti-N-methyl-d-aspartate receptor encephalitis in southern Brazil: a cases series and review of the literature

Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care

Disturbed effective connectivity patterns in an intrinsic triple network model are associated with posttraumatic stress disorder

Highlights of the Issue 2, 2019